Pfizer Ltd
NSE:PFIZER
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4 031.9
6 318.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Pfizer Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | IN |
Market Cap | 240.8B INR |
Gross Margin |
65%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Gross Margin |
-3%
|
Country | US |
Market Cap | 749.7B USD |
Gross Margin |
81%
|
Country | UK |
Market Cap | 440.4B GBP |
Gross Margin |
56%
|
Country | DK |
Market Cap | 3.4T DKK |
Gross Margin |
85%
|
Country | US |
Market Cap | 372B USD |
Gross Margin |
69%
|
Country | US |
Market Cap | 257.3B USD |
Gross Margin |
77%
|
Country | CH |
Market Cap | 200.4B CHF |
Gross Margin |
73%
|
Country | UK |
Market Cap | 162.7B GBP |
Gross Margin |
82%
|
Country | CH |
Market Cap | 179.9B CHF |
Gross Margin |
75%
|
Country | IE |
Market Cap | 146B USD |
Gross Margin |
68%
|
Pfizer Ltd
Glance View
Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 2,285 full-time employees. The firm has a portfolio of approximately 150 products across over 15 therapeutic areas. The firm is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The firm offers a range of products for anti-diabetic, anti-infectives, cardiovascular, dermatology, erectile dysfunction, gastrointestinal (GI), multivitamins, neurology, pain/fever/inflammation and autoimmune disorders, among others. Its products include Trulimax, Vibazime DT, Viagra, Daxid, Tricorex, Mucaine, Diamox, Hetrazan, Enbrel, Ativan, Pacitane, Folvite Tablets, Autrin Capsules, Prevenar 13, Wysolone, Loette, Ovral G, Ovral L, Premarin tablets, Premarin Vaginal Cream, Zosyn, Wymox, Tygacil, Cynomycin, Targit, Cyklokapron and Magnamycin. The firm has its own manufacturing facility at Thane and Goa. The firm has various independent contract/third party manufacturers based across the country.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Pfizer Ltd's most recent financial statements, the company has Gross Margin of 65%.